$JFBR
Jeffs' Brands Ltd Stock $jfbr

$jfbr Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023028401 Filed on April 10, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$5.859M	$5.859M	$6.509M
YoY Change	-9.99%	-9.99%	184.36%
Cost Of Revenue	$5.060M	$5.060M	$4.560M
YoY Change	10.96%	10.96%	291.42%
Gross Profit	$799.0K	$799.0K	$1.949M
YoY Change	-59.0%	-59.0%	73.4%
Gross Profit Margin	13.64%	13.64%	29.94%
Selling, General & Admin	$5.311M	$5.311M	$2.794M
YoY Change	90.09%	133.96%	296.88%
% of Gross Profit	664.71%	664.71%	143.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$286.0K	$570.0K	$280.0K
YoY Change	2.14%	8.78%	418.52%
% of Gross Profit	35.79%	71.34%	14.37%
Operating Expenses	$5.311M	$5.311M	$2.881M
YoY Change	84.35%	84.35%	309.23%
Operating Profit	-$4.512M	-$4.512M	-$932.0K
YoY Change	384.12%	384.12%	-321.9%
Interest Expense	$2.305M	$2.380M	-$629.0K
YoY Change	-466.45%	-546.53%	171.12%
% of Operating Profit
Other Income/Expense, Net		-$75.00K
YoY Change		-31.82%
Pretax Income	-$2.207M	-$6.000K	-$1.561M
YoY Change	41.38%	-99.62%	-930.32%
Income Tax	-$6.000K	-$6.000K	-$21.00K
% Of Pretax Income
Net Earnings	-$2.201M	-$2.201M	-$1.540M
YoY Change	42.92%	42.92%	-1475.0%
Net Earnings / Revenue	-37.57%	-37.57%	-23.66%
Basic Earnings Per Share		-$0.47
Diluted Earnings Per Share	-$0.47	-$0.47	-$224.6K
COMMON SHARES
Basic Shares Outstanding	8.074M shares	4.644M shares
Diluted Shares Outstanding		4.644M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.137M	$8.137M	$393.0K
YoY Change	1970.48%	1970.48%
Cash & Equivalents	$8.137M	$8.137M	$393.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$1.791M	$1.791M	$1.227M
Prepaid Expenses
Receivables	$327.0K	$327.0K	$366.0K
Other Receivables	$779.0K	$779.0K	$36.00K
Total Short-Term Assets	$11.03M	$11.03M	$2.022M
YoY Change	445.7%	445.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.00K	$179.0K	$3.000K
YoY Change	1266.67%	5866.67%
Goodwill
YoY Change
Intangibles	$4.452M		$5.021M
YoY Change	-11.33%
Long-Term Investments
YoY Change
Other Assets	$110.0K	$110.0K	$366.0K
YoY Change	-69.95%	-69.95%
Total Long-Term Assets	$4.741M	$4.741M	$5.390M
YoY Change	-12.04%	-12.04%
TOTAL ASSETS
Total Short-Term Assets	$11.03M	$11.03M	$2.022M
Total Long-Term Assets	$4.741M	$4.741M	$5.390M
Total Assets	$15.78M	$15.78M	$7.412M
YoY Change	112.83%	112.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$131.0K	$131.0K	$167.0K
YoY Change	-21.56%	-21.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$86.00K	$86.00K	$927.0K
YoY Change	-90.72%	-90.72%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$640.0K	$640.0K	$2.211M
YoY Change	-71.05%	-71.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$3.634M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$2.314M	$2.314M
YoY Change
Total Long-Term Liabilities	$2.314M	$2.314M	$3.634M
YoY Change	-36.32%	-36.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$640.0K	$640.0K	$2.211M
Total Long-Term Liabilities	$2.314M	$2.314M	$3.634M
Total Liabilities	$2.954M	$2.954M	$6.159M
YoY Change	-52.04%	-52.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.678M		-$1.477M
YoY Change	149.02%
Common Stock	-$3.319M		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.82M	$12.82M	$1.253M
YoY Change
Total Liabilities & Shareholders Equity	$15.78M	$15.78M	$7.412M
YoY Change	112.83%	112.83%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$2.201M	-$2.201M	-$1.540M
YoY Change	42.92%	42.92%	-1475.0%
Depreciation, Depletion And Amortization	$286.0K	$570.0K	$280.0K
YoY Change	2.14%	8.78%	418.52%
Cash From Operating Activities	-$3.786M	-$4.840M	-$551.0K
YoY Change	587.11%	460.83%	-1477.5%
INVESTING ACTIVITIES
Capital Expenditures	$38.00K	$41.00K	-$2.000K
YoY Change	-2000.0%	-100.87%	100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$38.00K	-$41.00K	-$2.000K
YoY Change	1800.0%	-99.13%	100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.89M	$12.63M	796.0K
YoY Change	1394.22%	121.69%	241.63%
NET CHANGE
Cash From Operating Activities	-3.786M	-$4.840M	-551.0K
Cash From Investing Activities	-38.00K	-$41.00K	-2.000K
Cash From Financing Activities	11.89M	$12.63M	796.0K
Net Change In Cash	8.070M	$7.744M	243.0K
YoY Change	3220.99%	7492.16%	-10.66%
FREE CASH FLOW
Cash From Operating Activities	-$3.786M	-$4.840M	-$551.0K
Capital Expenditures	$38.00K	$41.00K	-$2.000K
Free Cash Flow	-$3.824M	-$4.881M	-$549.0K
YoY Change	596.54%	-226.22%	-1439.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41482
CY2022	dei	Entity Registrant Name EntityRegistrantName	Jeffs’ Brands Ltd
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	7 Mezada Street.
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Bnei Brak
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Israel
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	5126112
CY2022	dei	Entity Address Country EntityAddressCountry	IL
CY2022	dei	Contact Personnel Name ContactPersonnelName	Viki Hakmon
CY2022	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value per share
CY2022	dei	Trading Symbol TradingSymbol	JFBR
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8074217	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	1197
CY2022	dei	Auditor Name AuditorName	Brightman Almagor Zohar & Co.
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8137000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	393000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	327000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	366000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	779000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	36000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1791000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1227000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	11034000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	2022000	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	366000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4452000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5021000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	110000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	138000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	4741000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5390000	usd
CY2022Q4	us-gaap	Assets Assets	15775000	usd
CY2021Q4	us-gaap	Assets Assets	7412000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	131000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	167000	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	391000	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	715000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	32000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	265000	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	86000	usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	927000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	640000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2074000	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	3634000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2216000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	137000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	314000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2314000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4085000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2954000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6159000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	43567567	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4356757	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8074217	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8074217	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2893125	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2893125	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16499000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2730000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3678000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1477000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12821000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1253000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15775000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7412000	usd
CY2022	us-gaap	Revenues Revenues	5859000	usd
CY2021	us-gaap	Revenues Revenues	6509000	usd
CY2020	us-gaap	Revenues Revenues	2289000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5060000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4560000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1165000	usd
CY2022	us-gaap	Gross Profit GrossProfit	799000	usd
CY2021	us-gaap	Gross Profit GrossProfit	1949000	usd
CY2020	us-gaap	Gross Profit GrossProfit	1124000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1198000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1314000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	376000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4113000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1480000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	328000	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	87000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4512000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-932000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	420000	usd
CY2022	jfbr	Financialincome Expenses Net FinancialincomeExpensesNet	2305000	usd
CY2021	jfbr	Financialincome Expenses Net FinancialincomeExpensesNet	-629000	usd
CY2020	jfbr	Financialincome Expenses Net FinancialincomeExpensesNet	-232000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2207000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1561000	usd
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	188000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-21000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2201000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1540000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	112000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4643879	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2892347	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2888768	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	183000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	112000	usd
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	55000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	350000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1540000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	75000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1250000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	60000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1058000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1253000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2201000	usd
CY2022	us-gaap	Adjustment To Additional Paid In Capital Convertible Debt Instrument Issued At Substantial Premium AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium	769000	usd
CY2022	jfbr	Stock Issued During Period Issuance Of Ordinary Shares Upon Initial Public Offering Net Of Issuance Costs StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts	6194000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	26000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	3461000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3319000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12821000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2201000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1540000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	112000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	60000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	570000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	524000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	104000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	87000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	95000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	222000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2822000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	75000	usd
CY2022	jfbr	Accrued Interest And Amortization Of Discount On Related Party And Shareholders Loans AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans	203000	usd
CY2021	jfbr	Accrued Interest And Amortization Of Discount On Related Party And Shareholders Loans AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans	324000	usd
CY2020	jfbr	Accrued Interest And Amortization Of Discount On Related Party And Shareholders Loans AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans	162000	usd
CY2022	us-gaap	Short Term Lease Payments ShortTermLeasePayments	25000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-115000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-50000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	14000	usd
CY2022	jfbr	Issuance Costs On Derivative Liabilities IssuanceCostsOnDerivativeLiabilities	1416000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	282000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-43000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	40000	usd
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-40000	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	743000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	290000	usd
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-96000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	564000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	449000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	638000	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Related Parties Current IncreaseDecreaseInNotesPayableRelatedPartiesCurrent	-213000	usd
CY2021	us-gaap	Increase Decrease In Notes Payable Related Parties Current IncreaseDecreaseInNotesPayableRelatedPartiesCurrent	241000	usd
CY2020	us-gaap	Increase Decrease In Notes Payable Related Parties Current IncreaseDecreaseInNotesPayableRelatedPartiesCurrent	14000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-579000	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	254000	usd
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	323000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4840000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-863000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	126000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4728000	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4730000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-101000	usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	752000	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	981000	usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	1518000	usd
CY2021	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	134000	usd
CY2020	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	196000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	13391000	usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	4800000	usd
CY2020	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	250000	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	100000	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1102000	usd
CY2020	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	105000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1250000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12625000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5695000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	159000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7744000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	102000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	184000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	393000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	291000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	107000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8137000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	393000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	291000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	73000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	116000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	477000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2021	jfbr	Deferred Offering Costs Included In Other Payables DeferredOfferingCostsIncludedInOtherPayables	86000	usd
CY2021	jfbr	Sharebased Compensation Included In Deferred Offering Costs SharebasedCompensationIncludedInDeferredOfferingCosts	75000	usd
CY2022	jfbr	Issuance Of Ordinary Shares Upon Conversion Of Shareholders Loans IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans	2839000	usd
CY2022	jfbr	Substantial Modification Of Shareholders Loans Recorded In Equity SubstantialModificationOfShareholdersLoansRecordedInEquity	982000	usd
CY2022	jfbr	Right Of Use Assets Obtained In Exchange For Lease Liabilities RightOfUseAssetsObtainedInExchangeForLeaseLiabilities	152000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.023	pure
CY2022Q1	jfbr	Bonus Shares And Reverse Share Split Description BonusSharesAndReverseShareSplitDescription	the Company’s Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February 17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares. Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect to the two subsequent reverse share splits) ordinary shares.
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company’s Board of Directors approved a 0.806-for-1 reverse split of its issued and outstanding Ordinary Shares, effective as of May 3, 2022, pursuant to which holders of the Company’s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company’s Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June 16, 2022, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85 Ordinary Shares held as of such date. The reverse stock split proportionally reduced the number of the Company’s authorized share capital.
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2201000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4840000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3678000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	13400000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Use of estimates</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances, fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent liabilities, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group’s assets and liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p>
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1211000	usd
CY2020	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	371000	usd
CY2020Q4	jfbr	Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue	0	usd
CY2021	jfbr	Fair Value Of Warrant Liability To Be Issued To Thirdparty FairValueOfWarrantLiabilityToBeIssuedToThirdparty	62000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	366000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1783000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1066000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1791000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	1227000	usd
CY2021	jfbr	Change In Fair Value ChangeInFairValue	75000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P12M
CY2022	us-gaap	Revenue Recognition Customer Acquisitions RevenueRecognitionCustomerAcquisitions	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>j.</b></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Asset acquisition</b></p></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Group accounts for a transaction as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs are capitalized as part of the asset or assets acquired.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p>
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	20000	usd
CY2022Q4	jfbr	Present Value Of Lease Liability PresentValueOfLeaseLiability	141000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35000	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1163000	usd
CY2020	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense		usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.0833	pure
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q4	us-gaap	Supplies Supplies	641000	usd
CY2022Q4	us-gaap	Government Contract Receivable GovernmentContractReceivable	130000	usd
CY2021Q4	us-gaap	Government Contract Receivable GovernmentContractReceivable	35000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	8000	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	1000	usd
CY2022Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	779000	usd
CY2021Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	36000	usd
CY2022Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	228000	usd
CY2022Q4	us-gaap	Other Inventory In Transit OtherInventoryInTransit	8000	usd
CY2021Q4	us-gaap	Other Inventory In Transit OtherInventoryInTransit	161000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	570000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	524000	usd
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	104000	usd
CY2022	jfbr	Finite Lived Intangible Asset Amortization Method FiniteLivedIntangibleAssetAmortizationMethod	570000	usd
CY2021	us-gaap	Indefinite Lived Intangible Assets Written Off Related To Sale Of Business Unit IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit	87000	usd
CY2022	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2022	jfbr	Operating Lease Assets OperatingLeaseAssets	138000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	141000	usd
CY2022Q4	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P3Y
CY2022Q4	jfbr	Weighted Average Borrowing Rate WeightedAverageBorrowingRate	0.10	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	58000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	103000	usd
CY2022Q4	jfbr	Future Operating Lease Payments FutureOperatingLeasePayments	161000	usd
CY2022Q4	us-gaap	Us Government Agencies Securities At Carrying Value USGovernmentAgenciesSecuritiesAtCarryingValue	36000	usd
CY2021Q4	us-gaap	Us Government Agencies Securities At Carrying Value USGovernmentAgenciesSecuritiesAtCarryingValue	100000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	50000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	294000	usd
CY2022Q4	jfbr	Accrued Expenses And Other Payables AccruedExpensesAndOtherPayables	266000	usd
CY2021Q4	jfbr	Accrued Expenses And Other Payables AccruedExpensesAndOtherPayables	271000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	391000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	715000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	86000	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	101000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	111000	usd
CY2021Q4	jfbr	Third Party Loan ThirdPartyLoan	715000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	86000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	927000	usd
CY2022Q3	jfbr	Aggregates Amount AggregatesAmount	153000	usd
CY2022Q3	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	14000	usd
CY2022Q3	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.0999	pure
CY2022Q4	us-gaap	Loans Payable LoansPayable	86000	usd
CY2022Q2	jfbr	Aggregates Amount AggregatesAmount	152000	usd
CY2022Q2	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.0999	pure
CY2021Q3	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.01	pure
CY2021Q3	jfbr	Aggregate Amount AggregateAmount	250000	usd
CY2021Q3	jfbr	Principal Loan Amount PrincipalLoanAmount	750000	usd
CY2021Q3	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	62000	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	137000	usd
CY2021	us-gaap	Other Expenses OtherExpenses	14000	usd
CY2023Q2	jfbr	Aggregate Amount AggregateAmount	1000000	usd
CY2022Q1	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0.0325	pure
CY2022Q1	jfbr	Short Term Line Of Credits ShortTermLineOfCredits	400000	usd
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	200000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2021Q4	jfbr	Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue	137000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	8220000	usd
CY2022	jfbr	Change In Fair Value ChangeInFairValue	-2822000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	-3319000	usd
CY2022Q4	jfbr	Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue	-2216000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	62000	usd
CY2021Q4	jfbr	Derivative Liability DerivativeLiability	137000	usd
CY2022Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	4.04
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3717473	shares
CY2022	jfbr	Public Offering Price Per Share PublicOfferingPricePerShare	4.16
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1	shares
CY2022	jfbr	Additional Warrants AdditionalWarrants	425912	shares
CY2022Q4	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	4000	usd
CY2022	us-gaap	Derivative Cost Of Hedge Net Of Cash Received DerivativeCostOfHedgeNetOfCashReceived	13400000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2100000	usd
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.04
CY2022Q4	jfbr	Revenues Percentage RevenuesPercentage	0.023	pure
CY2022	jfbr	Related Party Fair Value RelatedPartyFairValue	2216000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	8245000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	3319	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	4950000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1316000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3634000	usd
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	250000	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	250000	usd
CY2020Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.04	pure
CY2020Q4	us-gaap	Defined Benefit Plan Funded Percentage DefinedBenefitPlanFundedPercentage	0.08	pure
CY2020Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2021Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	4000000	usd
CY2021Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	350000	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.04	pure
CY2021Q1	us-gaap	Interest Expense Other Short Term Borrowings InterestExpenseOtherShortTermBorrowings	1026000	usd
CY2021Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2021Q1	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.1179	pure
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	10000000	usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3821000	usd
CY2022Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	2839000	usd
CY2022Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	982000	usd
CY2022Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1463619	shares
CY2022Q3	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	393000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.23	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.28	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2207000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1561000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	188000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	12000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	94000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	126000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	94000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	126000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-18000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-115000	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-50000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-18000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-115000	usd
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-50000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-21000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2201000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1561000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	188000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-506000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-359000	usd
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	43000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-110000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-78000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	10000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	610000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	416000	usd
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	23000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	76000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	110000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	56000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	32000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	890000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	172000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1032000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	228000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	890000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	172000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	142000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	56000	usd
CY2021Q4	jfbr	Differences Between Tax Basis And Carrying Value Of Loans DifferencesBetweenTaxBasisAndCarryingValueOfLoans	-370000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	32000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	32000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	370000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	110000	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-314000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	3870000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	747000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	8074217	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2893125	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	43567567	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	4356757	shares
CY2020Q4	jfbr	Agreement Description AgreementDescription	Smart Pro entered into a definitive agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro, acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro’s’ previous shareholders in consideration for restricted American Depository Shares (“ADS”) of Medigus and a cash component. Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company, with the value of restricted ADS to be subject to downward adjustment based on Smart Pro’s 2020 results. In addition, Smart Pro’s current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject to Smart Pro ’s achievement of certain milestones throughout 2021.
CY2020Q4	jfbr	Issued And Outstanding Share Capital Percentage IssuedAndOutstandingShareCapitalPercentage	0.5001	pure
CY2020Q4	jfbr	Invest Amount InvestAmount	150000	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	60000	usd
CY2022Q1	jfbr	Issuance Of Bonus Shares IssuanceOfBonusShares	664.0547	shares
CY2022Q1	jfbr	Aggregate Issuance Shares AggregateIssuanceShares	6630547	shares
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.04
CY2022Q3	jfbr	Initial Exercise Price Expire InitialExercisePriceExpire	P5Y
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.02
CY2022Q3	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	2.02
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.02
CY2022Q4	jfbr	Additional Warrant Term AdditionalWarrantTerm	P5Y
CY2022Q4	jfbr	Revenues Percentage RevenuesPercentage	0.023	pure
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	6.06
CY2022Q4	jfbr	Additional Warrants Description AdditionalWarrantsDescription	On November 28, 2022, following the issuance of the Additional warrants, the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser valuation, was recorded as a component of Group’s shareholder’s equity. (Refer also to Note 9c). The total gross consideration was 15.5 million (including the exercise of the underwriter’s option at the amount of $4 thousands). $8,245 thousand was initially attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been recorded in equity as a reduction of the paid in capital.
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	185873	shares
CY2022Q3	jfbr	Gross Proceeds GrossProceeds	58000	usd
CY2022Q3	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	4000	usd
CY2022Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1000	usd
CY2022Q4	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	1307027	shares
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-2822000	usd
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-14000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	2822000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	14000	usd
CY2022	jfbr	Finance Expenses In Respect Of Thirdparty Loan FinanceExpensesInRespectOfThirdpartyLoan	83000	usd
CY2021	jfbr	Finance Expenses In Respect Of Thirdparty Loan FinanceExpensesInRespectOfThirdpartyLoan	77000	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	75000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	85000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	156000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10000	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	203000	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	381000	usd
CY2020	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	221000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	38000	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	15000	usd
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	11000	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	517000	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	643000	usd
CY2020	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	232000	usd
CY2022	jfbr	Finance Expense Net FinanceExpenseNet	-2305000	usd
CY2021	jfbr	Finance Expense Net FinanceExpenseNet	629000	usd
CY2020	jfbr	Finance Expense Net FinanceExpenseNet	232000	usd
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2888768	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2892347	shares
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2201000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1540000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	112000	usd
CY2022	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	4643879	shares
CY2021	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	2892347	shares
CY2020	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	2888768	shares
CY2022	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.47
CY2021	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.53
CY2020	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	0.04
CY2022	jfbr	Ipo And Additional Warrants IPOAndAdditionalWarrants	6541998	shares
CY2022	jfbr	Underwriter Warrants UnderwriterWarrants	611785	shares
CY2022	jfbr	Other Warrants OtherWarrants	78661	shares
CY2022	jfbr	Total Diluted Weighted Average Shares Outstanding TotalDilutedWeightedAverageSharesOutstanding	7232444	shares
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	358000	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	192000	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	172000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	218000	usd
CY2022	jfbr	Interest Expenses On Loans From Related Parties And Shareholders InterestExpensesOnLoansFromRelatedPartiesAndShareholders	203000	usd
CY2021	jfbr	Interest Expenses On Loans From Related Parties And Shareholders InterestExpensesOnLoansFromRelatedPartiesAndShareholders	381000	usd
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	951000	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	573000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q4	jfbr	Advances To Suppliers AdvancesToSuppliers	228000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	228000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	32000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	265000	usd
CY2021Q4	jfbr	Loans From Shareholders LoansFromShareholders	3634000	usd
CY2021Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	111000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	32000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	4010000	usd
	jfbr	Related Party Fair Value RelatedPartyFairValue	60000	usd
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	60000	usd
CY2022Q3	jfbr	Bonus Bonus	480000	ils
CY2022Q3	jfbr	Bonus Bonus	140000	usd
CY2022Q4	jfbr	Consultancy Services Fees ConsultancyServicesFees	57500	ils
CY2022Q4	jfbr	Consultancy Services Fees ConsultancyServicesFees	16500	usd
CY2022Q4	jfbr	Bonus Bonus	425000	ils
CY2022Q4	jfbr	Bonus Bonus	121000	usd
CY2022Q4	jfbr	Percentage Of Gross Proceed PercentageOfGrossProceed	0.07	pure
CY2022Q4	jfbr	Percentage Of Total Consideration Paid PercentageOfTotalConsiderationPaid	0.08	pure
CY2022Q4	jfbr	Undefined Period Of Time UndefinedPeriodOfTime	P3Y
CY2022	us-gaap	Payments To Suppliers PaymentsToSuppliers	228000	usd
CY2022Q2	jfbr	Percentage Lease And Maintenance Expenses Related PercentageLeaseAndMaintenanceExpensesRelated	0.50	pure
CY2022	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	86000	usd
CY2022	jfbr	Outstanding Payable OutstandingPayable	32000	usd
CY2022Q3	us-gaap	Related Party Costs RelatedPartyCosts	150	usd
CY2022Q3	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	175	usd
CY2022Q3	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	393000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	288238	usd
CY2022	jfbr	Additional Dividends Payable Shares Value AdditionalDividendsPayableSharesValue	300000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense		usd
CY2021	us-gaap	Short Term Lease Payments ShortTermLeasePayments		usd
CY2020	us-gaap	Short Term Lease Payments ShortTermLeasePayments		usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2021	jfbr	Issuance Costs On Derivative Liabilities IssuanceCostsOnDerivativeLiabilities		usd
CY2020	jfbr	Issuance Costs On Derivative Liabilities IssuanceCostsOnDerivativeLiabilities		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2020	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	jfbr	Deferred Offering Costs Included In Other Payables DeferredOfferingCostsIncludedInOtherPayables		usd
CY2020	jfbr	Deferred Offering Costs Included In Other Payables DeferredOfferingCostsIncludedInOtherPayables		usd
CY2022	jfbr	Sharebased Compensation Included In Deferred Offering Costs SharebasedCompensationIncludedInDeferredOfferingCosts		usd
CY2020	jfbr	Sharebased Compensation Included In Deferred Offering Costs SharebasedCompensationIncludedInDeferredOfferingCosts		usd
CY2021	jfbr	Right Of Use Assets Obtained In Exchange For Lease Liabilities RightOfUseAssetsObtainedInExchangeForLeaseLiabilities		usd
CY2020	jfbr	Right Of Use Assets Obtained In Exchange For Lease Liabilities RightOfUseAssetsObtainedInExchangeForLeaseLiabilities		usd
CY2022	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P3M
CY2021Q4	us-gaap	Supplies Supplies		usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties		usd
CY2022Q4	jfbr	Third Party Loan ThirdPartyLoan		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount		usd
CY2022	jfbr	Current State And Local Tax Expenses Benefit CurrentStateAndLocalTaxExpensesBenefit		usd
CY2021	jfbr	Current State And Local Tax Expenses Benefit CurrentStateAndLocalTaxExpensesBenefit		usd
CY2020	jfbr	Current State And Local Tax Expenses Benefit CurrentStateAndLocalTaxExpensesBenefit		usd
CY2022	jfbr	Deferred State And Local Income Tax Expenses Benefit DeferredStateAndLocalIncomeTaxExpensesBenefit		usd
CY2021	jfbr	Deferred State And Local Income Tax Expenses Benefit DeferredStateAndLocalIncomeTaxExpensesBenefit		usd
CY2020	jfbr	Deferred State And Local Income Tax Expenses Benefit DeferredStateAndLocalIncomeTaxExpensesBenefit		usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2020	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2020	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2020	jfbr	Finance Expenses In Respect Of Thirdparty Loan FinanceExpensesInRespectOfThirdpartyLoan		usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2020	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2888768	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2892347	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4643879	shares
CY2020	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	0.04
CY2022	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.47
CY2021	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.53
CY2021	jfbr	Ipo And Additional Warrants IPOAndAdditionalWarrants		shares
CY2020	jfbr	Ipo And Additional Warrants IPOAndAdditionalWarrants		shares
CY2021	jfbr	Underwriter Warrants UnderwriterWarrants		shares
CY2020	jfbr	Underwriter Warrants UnderwriterWarrants		shares
CY2021	jfbr	Other Warrants OtherWarrants		shares
CY2020	jfbr	Other Warrants OtherWarrants		shares
CY2021	jfbr	Total Diluted Weighted Average Shares Outstanding TotalDilutedWeightedAverageSharesOutstanding		shares
CY2020	jfbr	Total Diluted Weighted Average Shares Outstanding TotalDilutedWeightedAverageSharesOutstanding		shares
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees		usd
CY2021	us-gaap	Professional Fees ProfessionalFees		usd
CY2021Q4	jfbr	Advances To Suppliers AdvancesToSuppliers		usd
CY2021Q4	us-gaap	Other Assets OtherAssets		usd
CY2022Q4	jfbr	Loans From Shareholders LoansFromShareholders		usd
CY2022Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001885408

Files In Submission

Name	View Source	Status
0001213900-23-028401-index-headers.html	Edgar Link	pending
0001213900-23-028401-index.html	Edgar Link	pending
0001213900-23-028401.txt	Edgar Link	pending
0001213900-23-028401-xbrl.zip	Edgar Link	pending
f20f2022ex12-1_jeffsbrands.htm	Edgar Link	pending
f20f2022ex12-2_jeffsbrands.htm	Edgar Link	pending
f20f2022ex13-1_jeffsbrands.htm	Edgar Link	pending
f20f2022ex13-2_jeffsbrands.htm	Edgar Link	pending
f20f2022ex15-1_jeffsbrands.htm	Edgar Link	pending
f20f2022ex2-5_jeffsbrands.htm	Edgar Link	pending
f20f2022ex4-24_jeffsbrands.htm	Edgar Link	pending
f20f2022ex8-1_jeffsbrands.htm	Edgar Link	pending
f20f2022_jeffsbrands.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
jfbr-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
jfbr-20221231_cal.xml	Edgar Link	unprocessable
jfbr-20221231_def.xml	Edgar Link	unprocessable
jfbr-20221231_lab.xml	Edgar Link	unprocessable
jfbr-20221231_pre.xml	Edgar Link	unprocessable
f20f2022_jeffsbrands_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JFBR
Jeffs' Brands Ltd Stock $jfbr

2022 Q4 Form 20-F Financial Statement

#000121390023028401 Filed on April 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFBR Jeffs' Brands Ltd Stock $jfbr

2022 Q4 Form 20-F Financial Statement

#000121390023028401 Filed on April 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFBR
Jeffs' Brands Ltd Stock $jfbr